Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccine.
Saved in:
| Title: | Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccine. |
|---|---|
| Authors: | Nielsen CM; University of Oxford, Oxford, Oxfordshire, United Kingdom., Barrett JR; University of Oxford, Oxford, Oxfordshire, United Kingdom., Davis C; Department of Biological Engineering, MIT, Cambridge, Massachusetts, USA., Fallon JK; Ragon Institute of Massachusetts General Hospital (MGH), MIT and Harvard, Boston, Massachusetts, USA., Goh C; University of Oxford, Oxford, Oxfordshire, United Kingdom., Michell AR; Ragon Institute of Massachusetts General Hospital (MGH), MIT and Harvard, Boston, Massachusetts, USA., Griffin C; Department of Biological Engineering, MIT, Cambridge, Massachusetts, USA., Kwok A; University of Oxford, Oxford, Oxfordshire, United Kingdom.; Wellcome Center for Human Genetics, University of Oxford, Oxford, Oxfordshire, United Kingdom., Loos C; Department of Biological Engineering, MIT, Cambridge, Massachusetts, USA.; Ragon Institute of Massachusetts General Hospital (MGH), MIT and Harvard, Boston, Massachusetts, USA., Darko S; Vaccine Research Center, NIAID/NIH, Bethesda, Maryland, USA., Laboune F; Vaccine Research Center, NIAID/NIH, Bethesda, Maryland, USA., Tekman M; Institute of Experimental and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Diouf A; Laboratory of Malaria and Vector Research, NIAID/NIH, Rockville, Maryland, USA., Miura K; Laboratory of Malaria and Vector Research, NIAID/NIH, Rockville, Maryland, USA., Francica JR; Vaccine Research Center, NIAID/NIH, Bethesda, Maryland, USA., Ransier A; Vaccine Research Center, NIAID/NIH, Bethesda, Maryland, USA., Long CA; Laboratory of Malaria and Vector Research, NIAID/NIH, Rockville, Maryland, USA., Silk SE; University of Oxford, Oxford, Oxfordshire, United Kingdom., Payne RO; University of Oxford, Oxford, Oxfordshire, United Kingdom., Minassian AM; University of Oxford, Oxford, Oxfordshire, United Kingdom., Lauffenburger DA; Department of Biological Engineering, MIT, Cambridge, Massachusetts, USA., Seder RA; Vaccine Research Center, NIAID/NIH, Bethesda, Maryland, USA., Douek DC; Vaccine Research Center, NIAID/NIH, Bethesda, Maryland, USA., Alter G; Ragon Institute of Massachusetts General Hospital (MGH), MIT and Harvard, Boston, Massachusetts, USA., Draper SJ; University of Oxford, Oxford, Oxfordshire, United Kingdom. |
| Source: | JCI insight [JCI Insight] 2023 Jan 24; Vol. 8 (2). Date of Electronic Publication: 2023 Jan 24. |
| Publication Type: | Journal Article; Research Support, N.I.H., Intramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model: Electronic Cited Medium: Internet ISSN: 2379-3708 (Electronic) Linking ISSN: 23793708 NLM ISO Abbreviation: JCI Insight Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36692019 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccine. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Nielsen+CM%22">Nielsen CM</searchLink>; University of Oxford, Oxford, Oxfordshire, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Barrett+JR%22">Barrett JR</searchLink>; University of Oxford, Oxford, Oxfordshire, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Davis+C%22">Davis C</searchLink>; Department of Biological Engineering, MIT, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Fallon+JK%22">Fallon JK</searchLink>; Ragon Institute of Massachusetts General Hospital (MGH), MIT and Harvard, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Goh+C%22">Goh C</searchLink>; University of Oxford, Oxford, Oxfordshire, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Michell+AR%22">Michell AR</searchLink>; Ragon Institute of Massachusetts General Hospital (MGH), MIT and Harvard, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Griffin+C%22">Griffin C</searchLink>; Department of Biological Engineering, MIT, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Kwok+A%22">Kwok A</searchLink>; University of Oxford, Oxford, Oxfordshire, United Kingdom.; Wellcome Center for Human Genetics, University of Oxford, Oxford, Oxfordshire, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Loos+C%22">Loos C</searchLink>; Department of Biological Engineering, MIT, Cambridge, Massachusetts, USA.; Ragon Institute of Massachusetts General Hospital (MGH), MIT and Harvard, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Darko+S%22">Darko S</searchLink>; Vaccine Research Center, NIAID/NIH, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Laboune+F%22">Laboune F</searchLink>; Vaccine Research Center, NIAID/NIH, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Tekman+M%22">Tekman M</searchLink>; Institute of Experimental and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.<br /><searchLink fieldCode="AU" term="%22Diouf+A%22">Diouf A</searchLink>; Laboratory of Malaria and Vector Research, NIAID/NIH, Rockville, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Miura+K%22">Miura K</searchLink>; Laboratory of Malaria and Vector Research, NIAID/NIH, Rockville, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Francica+JR%22">Francica JR</searchLink>; Vaccine Research Center, NIAID/NIH, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Ransier+A%22">Ransier A</searchLink>; Vaccine Research Center, NIAID/NIH, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Long+CA%22">Long CA</searchLink>; Laboratory of Malaria and Vector Research, NIAID/NIH, Rockville, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Silk+SE%22">Silk SE</searchLink>; University of Oxford, Oxford, Oxfordshire, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Payne+RO%22">Payne RO</searchLink>; University of Oxford, Oxford, Oxfordshire, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Minassian+AM%22">Minassian AM</searchLink>; University of Oxford, Oxford, Oxfordshire, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Lauffenburger+DA%22">Lauffenburger DA</searchLink>; Department of Biological Engineering, MIT, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Seder+RA%22">Seder RA</searchLink>; Vaccine Research Center, NIAID/NIH, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Douek+DC%22">Douek DC</searchLink>; Vaccine Research Center, NIAID/NIH, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Alter+G%22">Alter G</searchLink>; Ragon Institute of Massachusetts General Hospital (MGH), MIT and Harvard, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Draper+SJ%22">Draper SJ</searchLink>; University of Oxford, Oxford, Oxfordshire, United Kingdom. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101676073%22">JCI insight</searchLink> [JCI Insight] 2023 Jan 24; Vol. 8 (2). <i>Date of Electronic Publication: </i>2023 Jan 24. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Intramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+for+Clinical+Investigation%22">American Society for Clinical Investigation </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101676073 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2379-3708 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223793708%22">23793708 </searchLink><i>NLM ISO Abbreviation: </i>JCI Insight <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36692019 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1172/jci.insight.163859 Languages: – Code: eng Text: English Titles: – TitleFull: Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccine. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Nielsen CM – PersonEntity: Name: NameFull: Barrett JR – PersonEntity: Name: NameFull: Davis C – PersonEntity: Name: NameFull: Fallon JK – PersonEntity: Name: NameFull: Goh C – PersonEntity: Name: NameFull: Michell AR – PersonEntity: Name: NameFull: Griffin C – PersonEntity: Name: NameFull: Kwok A – PersonEntity: Name: NameFull: Loos C – PersonEntity: Name: NameFull: Darko S – PersonEntity: Name: NameFull: Laboune F – PersonEntity: Name: NameFull: Tekman M – PersonEntity: Name: NameFull: Diouf A – PersonEntity: Name: NameFull: Miura K – PersonEntity: Name: NameFull: Francica JR – PersonEntity: Name: NameFull: Ransier A – PersonEntity: Name: NameFull: Long CA – PersonEntity: Name: NameFull: Silk SE – PersonEntity: Name: NameFull: Payne RO – PersonEntity: Name: NameFull: Minassian AM – PersonEntity: Name: NameFull: Lauffenburger DA – PersonEntity: Name: NameFull: Seder RA – PersonEntity: Name: NameFull: Douek DC – PersonEntity: Name: NameFull: Alter G – PersonEntity: Name: NameFull: Draper SJ IsPartOfRelationships: – BibEntity: Dates: – D: 24 M: 01 Text: 2023 Jan 24 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 2379-3708 Numbering: – Type: volume Value: 8 – Type: issue Value: 2 Titles: – TitleFull: JCI insight Type: main |
| ResultId | 1 |